Nitto Avecia
Michael Amend has over 20 years of experience in oligonucleotide development and production. Michael currently works at Nitto Avecia as the Associate Director of Talent Acquisition. In this role, they are responsible for providing innovative ideas and flexible solutions to build value for customers in the advancing oligo therapeutic market. Michael previously worked at MEDITECH, where they held various roles, including Supervisor, Recruiting and Staff Development, Recruiting & Staff Development Analyst, Senior Training Specialist, Staff Development, and Recruiting Specialist. At MEDITECH, they oversaw projects and programs related to candidate sourcing, employment branding, onboarding, and continuing career development, and designed and facilitated training programs for both management and front-line staff.
Michael Amend holds a Bachelor of Arts degree in Film Studies from Rhode Island College, which they obtained in 2006. In addition to their degree, they have obtained several certifications, including "Managing Up as an Employee" from LinkedIn in October 2021, "Building Connection and Engagement in Virtual Teams" from LinkedIn in September 2021, "Coaching Skills for Leaders and Managers" from LinkedIn in January 2021, "Unconscious Bias" from LinkedIn in September 2020, "SHRM - Certified Professional (SHRM-CP)" from SHRM in June 2019. Michael also has an "Everything DiSC Workplace® Certification - Online," however, the specific month and year of obtaining it are not provided.
This person is not in any teams
Nitto Avecia
1 followers
Oligonucleotides are giving rise to a new generation of therapeutics—and Nitto Avecia is helping lead the way. With more than 25 years’ experience in oligonucleotide development and production, we are the partner of choice for pharmaceutical innovators creating new drugs with the power to transform treatment for a wide range of diseases. In partnership with Nitto Avecia Pharma Services, Nitto Avecia is the first CMO that offers a comprehensive, end-to-end oligonucleotide solution. This offers the advantage of a single, expert partner handling the entire process—from drug substance through drug product manufacturing—with flexible solutions and consistent reliability and quality.